388 related articles for article (PubMed ID: 26308419)
1. Hepatocellular Carcinoma Progression While on Waiting List for Liver Transplantation.
Giacomoni A; Concone G; Di Sandro S; Lauterio A; De Carlis L
Transplantation; 2015 Sep; 99(9):e155-6. PubMed ID: 26308419
[No Abstract] [Full Text] [Related]
2. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
[TBL] [Abstract][Full Text] [Related]
3. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
4. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.
Li HL; Ji WB; Zhao R; Duan WD; Chen YW; Wang XQ; Yu Q; Luo Y; Dong JH
World J Gastroenterol; 2015 Mar; 21(12):3599-606. PubMed ID: 25834326
[TBL] [Abstract][Full Text] [Related]
5. Locoregional therapy and recurrence of hepatocellular carcinoma after liver transplant.
Kırnap M; Boyvat F; Akdur A; Karakayalı F; Arslan G; Moray G; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():166-9. PubMed ID: 24635819
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma downstaging in liver transplantation.
Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
[TBL] [Abstract][Full Text] [Related]
7. Effect of Downstaging and Bridging of Hepatocellular Carcinoma on Survival Following Liver Transplant: A Single Center Experience.
Al Sebayel MI; Elsiesy H; Al-Hamoudi W; Alabbad S; ElSheikh Y; Elbeshbeshy H; Salih I; Yousif S; Saleh Y; Eldali A; Abaalkhail FA
Exp Clin Transplant; 2017 Mar; 15(Suppl 2):7-11. PubMed ID: 28301992
[TBL] [Abstract][Full Text] [Related]
8. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.
Pompili M; Francica G; Ponziani FR; Iezzi R; Avolio AW
World J Gastroenterol; 2013 Nov; 19(43):7515-30. PubMed ID: 24282343
[TBL] [Abstract][Full Text] [Related]
9. Multimodality therapy and liver transplantation for hepatocellular carcinoma: a 14-year prospective analysis of outcomes.
Ramanathan R; Sharma A; Lee DD; Behnke M; Bornstein K; Stravitz RT; Sydnor M; Fulcher A; Cotterell A; Posner MP; Fisher RA
Transplantation; 2014 Jul; 98(1):100-6. PubMed ID: 24503764
[TBL] [Abstract][Full Text] [Related]
10. Is the treatment of hepatocellular carcinoma on the waiting list necessary?
Majno P; Lencioni R; Mornex F; Girard N; Poon RT; Cherqui D
Liver Transpl; 2011 Oct; 17 Suppl 2():S98-108. PubMed ID: 21954097
[No Abstract] [Full Text] [Related]
11. Analysis of Preoperative Portal Vein Embolization Outcomes in Patients with Hepatocellular Carcinoma: A Single-Center Experience.
Marti J; Giacca M; Alshebeeb K; Bahl S; Hua C; Horn JC; BouAyache J; Patel R; Facciuto M; Schwartz M; Florman S; Kim E; Gunasekaran G
J Vasc Interv Radiol; 2018 Jul; 29(7):920-926. PubMed ID: 29735260
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter arterial chemoembolization followed by immediate radiofrequency ablation for large solitary hepatocellular carcinomas.
Wang ZJ; Wang MQ; Duan F; Song P; Liu FY; Chang ZF; Wang Y; Yan JY; Li K
World J Gastroenterol; 2013 Jul; 19(26):4192-9. PubMed ID: 23864783
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hepatocellular carcinoma: pathologic results after chemoembolization and liver transplantation.
Roumilhac D; Sergent G; Pruvot FR; Talbodec N; Gamblez L; Ernst O; Paris JC; L'herminé C; Lecomte-Houcke M
Transplant Proc; 1999; 31(1-2):416-7. PubMed ID: 10083168
[No Abstract] [Full Text] [Related]
14. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.
Graziadei IW; Sandmueller H; Waldenberger P; Koenigsrainer A; Nachbaur K; Jaschke W; Margreiter R; Vogel W
Liver Transpl; 2003 Jun; 9(6):557-63. PubMed ID: 12783395
[TBL] [Abstract][Full Text] [Related]
15. Necrosis percentage of radiologically treated hepatocellular carcinoma at hepatectomy for liver transplantation.
Rossetto A; Adani GL; Baccarani U; Bresadola V; Lorenzin D; Sponza M; Vit A; De Anna D; Bresadola F
Transplant Proc; 2011 May; 43(4):1095-7. PubMed ID: 21620061
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and nontarget effects of transarterial chemoembolization in bridging of hepatocellular carcinoma patients to liver transplantation: a histopathologic study.
Stampfl U; Bermejo JL; Sommer CM; Hoffmann K; Weiss KH; Schirmacher P; Schemmer P; Kauczor HU; Richter GM; Radeleff BA; Longerich T
J Vasc Interv Radiol; 2014 Jul; 25(7):1018-1026.e4. PubMed ID: 24768235
[TBL] [Abstract][Full Text] [Related]
17. Short-term interval combined chemoembolization and radiofrequency ablation for hepatocellular carcinoma.
Choe WH; Kim YJ; Park HS; Park SW; Kim JH; Kwon SY
World J Gastroenterol; 2014 Sep; 20(35):12588-94. PubMed ID: 25253962
[TBL] [Abstract][Full Text] [Related]
18. Management of hepatocellular carcinoma on the waiting list before liver transplantation: time for controlled trials?
Majno P; Giostra E; Mentha G
Liver Transpl; 2007 Nov; 13(11 Suppl 2):S27-35. PubMed ID: 17969086
[No Abstract] [Full Text] [Related]
19. Safety and feasibility of same-day discharge of patients with hepatocellular carcinoma treated with transarterial chemoembolization with drug-eluting beads in a liver transplantation program.
Nasser F; Cavalcante RN; Galastri FL; de Rezende MB; Felga GG; Travassos FB; De Fina B; Affonso BB
J Vasc Interv Radiol; 2014 Jul; 25(7):1012-7. PubMed ID: 24704346
[TBL] [Abstract][Full Text] [Related]
20. Association of Complete Radiologic and Pathologic Response following Locoregional Therapy before Liver Transplantation with Long-Term Outcomes of Hepatocellular Carcinoma: A Retrospective Study.
Habibollahi P; Shamchi SP; Choi JM; Gade TP; Stavropoulos SW; Hunt SJ; Dagli M; Sudheendra D; Mondschein JI; Soulen MC; Nadolski GJ
J Vasc Interv Radiol; 2019 Mar; 30(3):323-329. PubMed ID: 30819472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
